Esomeprazole, 8.5% w/w
| Product | Esomeprazole, 8.5% w/w |
| Pharmaceutical Form | Ready to fill pellets |
| Strengths | 8.5%, 15%, 22.5% |
| Release Charecteristics | Delayed Release (like AstraZeneca – Nexium 20 mg & 40 mg Capsules) |
| Indications | Treatment of Gastroesophageal Reflux Disease (GERD) |
| Posology | Once daily |
| Raw Material | DMF available |
| Technical Documents | Available in CTD format |
| Registration underway | Iran |
| Marketing | Syria, Egypt, Yemen |
Description
